GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (BSP:M1RN34) » Definitions » Sale Of Investment

Moderna (BSP:M1RN34) Sale Of Investment : R$40,963 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Moderna Sale Of Investment?

Moderna's sale of investment for the three months ended in Mar. 2024 was R$14,232 Mil. It means Moderna gained R$14,232 Mil from selling investments. Moderna's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was R$40,963 Mil.

Compared with last quarter (R$6,590 Mil in Dec. 2023 ), Moderna gained more money from selling investments in Mar. 2024 (R$14,232 Mil).

Moderna Sale Of Investment Historical Data

The historical data trend for Moderna's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna Sale Of Investment Chart

Moderna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial 4,769.43 6,955.63 25,124.72 35,138.94 43,025.14

Moderna Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17,276.93 11,522.68 8,618.03 6,590.23 14,232.27

Moderna Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$40,963 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Moderna Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Moderna's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Moderna (BSP:M1RN34) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (BSP:M1RN34) » Definitions » Sale Of Investment
Comparable Companies
BNTX BGNE ALNY SGEN BMRN RPRX LEGN INCY UTHR SRPT OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 HKSE:02269 XBRU:ARGX SZSE:300122 OCSE:GMAB XKRX:068270
Traded in Other Exchanges
MRNA:USA MRNA:Peru MRNA:Mexico 0QFd:UK 0A45:UK 0QF:Germany MRNA:Austria
Address
200 Technology Square, Cambridge, MA, USA, 02139
Website
https://www.modernatx.com
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Moderna (BSP:M1RN34) Headlines

No Headlines